Business

Will Marijuana Stocks Continue to Surge in June?

Marijuana stocks saw a good rise in May. Higher demand amid the COVID-19 pandemic led to increasing sales. Many cannabis companies reported good quarterly numbers last month—a recovery in the sector. Cannabis 2.0 products continue to launch, which could be the turnaround factor. The Horizons Marijuana Life Sciences ETF, which tracks the North American cannabis industry, rose 20%, while the SPDR S&P 500 ETF rose 7.6% in May. Let’s take a look at how the marijuana sector performed last month and what you can expect in June.

The 3 Must-Knows of Cannabis Stock Investing

Marijuana is a high-growth industry. However, there are a few things you should know before investing in the green rush.

For years, there wasn't a hotter investment on Wall Street than cannabis stocks. Investors with the wherewithal and stomach to have invested in some of the most prominent pot stocks in 2016 or 2017 found themselves up, in some cases, by quadruple digits during the first quarter of 2019. In fact, more than a dozen pot stocks rocketed higher by at least 70% in Q1 2019.

Why Some Cannabis Multi-State Operators Are Prospering During Tough Times

A number of multistate marijuana operators are struggling, unloading assets, cutting jobs and overhead costs as well as scrapping expansion plans amid a looming recession and a shortage of investor funding.

But other MSOs are doing well financially: Cresco Labs, Curaleaf, Green Thumb Industries and Trulieve, among others.

Stock underperformers had best-paid cannabis executives

Tilray Inc., Acreage Holdings Inc., and Sunniva Inc. had the highest-paid executives and directors among cannabis companies, according to a new survey by Bedford Consulting Group.

The report examined the compensation of 437 executives and 449 board members at 96 pot firms. The data was collected in October, when the average cannabis share price was about one-third higher than it is today.

Another record month for medical marijuana sales in Oklahoma

Oklahoma's medical marijuana industry continues to break sales records.

Dispensaries remitted nearly $5.1 million via the state's 7% tax on cannabis, meaning customers spent approximately $73.8 million on medical marijuana in April, according to data released by state tax officials..

It's the fourth month in a row sales increased compared with the previous month, a trend that highlights a growing demand for the product more than a year after dispensaries first opened their doors.

The world's largest marijuana company craters 22% as recreational pot demand sinks amid coronavirus pandemic (CGC)

  • Canopy Growth cratered as much as 22% on Friday after the company reported its fiscal fourth quarter earnings that missed analyst estimates.
  • The coronavirus pandemic took a toll on the Canadian marijuana company after it was forced to close its corporate-owned retail stores in mid-March.
  • Additionally, the company saw a 14% decline in its direct-to-consumer sales in the quarter, which Canopy attributed to "off peak seasonal demand decline."
  • Canopy withdrew its financial guidance for fiscal-year 20